Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery · Stony Brook, NY
NPI
1093158081
Since 2013
Specialty
Obstetrics & Gynecology, Female Pelvic Medicine and Reconstructive Surgery
Code 207VF0040X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Stony Brook University Medical Ctr, Department of OB/GYN, Hsc, T9
Stony Brook, NY, 11794
Phone (631) 444-4686
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,576 services
Medicare patients, 2024
190
Average age 75
Drug cost, 2024
$137K
518 prescriptions
Company payments, 2025
$1,094
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andre Plair was code 99213 (office e&m - established), 196 times for 117 patients. In total Andre Plair billed 1,576 services in 49 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 196 | 117 | $78.13 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 177 | 100 | $14.47 | $2,561 |
| 99214 Office E&M - Established | Office | 120 | 84 | $111.20 | $13K |
| 51798 Ultrasound - Nonspecific | Office | 116 | 102 | $10.15 | $1,178 |
| 99459 Office/Outpatient Services | Office | 89 | 73 | $21.30 | $1,896 |
| 81003 Clinical Chemistry | Office | 53 | 42 | $2.20 | $117 |
| 99212 Office E&M - Established | Office | 43 | 41 | $50.54 | $2,173 |
| 99204 Office E&M - New | Office | 27 | 27 | $143.94 | $3,886 |
| 51701 Other Organ Systems | Office | 24 | 18 | $41.30 | $991 |
| 51741 Test - Miscellaneous | Office | 23 | 20 | $7.56 | $174 |
| 51728 Other Organ Systems | Office | 20 | 19 | $335.88 | $6,718 |
| 51797 Other Organ Systems | Office | 20 | 19 | $164.97 | $3,299 |
| 51784 Neurologic | Office | 19 | 18 | $29.49 | $560 |
| 99215 Office E&M - Established | Office | 16 | 14 | $156.78 | $2,508 |
| 52000 Cystourethroscopy | Office | 16 | 16 | $200.82 | $3,213 |
By year: 2022 $85K for 724 services; 2023 $102K for 1,214 services; 2024 $90K for 1,576 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 53 | 42 | $2.20 | $117 |
Medicare prescription drug claims, 2024
In 2024, the drug Andre Plair prescribed most often to Medicare patients was Estradiol, with 95 prescriptions and refills. In total Andre Plair wrote 518 Medicare prescriptions that cost $137K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 95 | 204 | 57 | $7,653 |
| Myrbetriq Mirabegron | 57 | 121 | 22 | $54K |
| Darifenacin Er Darifenacin Hydrobromide | 40 | 97 | 16 | $13K |
| Gemtesa Vibegron | 36 | 82 | 19 | $36K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 36 | 29 | $107 |
| Ciprofloxacin Hcl Generic | 22 | 22 | 19 | $148 |
| Cephalexin Generic | 18 | 18 | 15 | $58.72 |
| Fluconazole Generic | 17 | 19 | 15 | $108 |
| Trospium Chloride Generic | 16 | 27 | Under 11 | $506 |
| Methenamine Hippurate Generic | 15 | 27 | Under 11 | $1,437 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 14 | 14 | 13 | $136 |
| Trimethoprim Generic | 12 | 22 | Under 11 | $428 |
| Fosfomycin Tromethamine Generic | 11 | 17 | Under 11 | $3,607 |
Brand drugs: 120 claims; generic drugs: 398 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andre Plair $1,094 ($1,094 in general payments such as food, travel and fees) from 4 companies. The largest payer was Medtronic, Inc. with $875.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.